Skip to main content
logo
Enorama Pharma AB (publ) (STO:ERMA)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.6860
-0.0140 (-2.00%)
Sep 25, 2026, 9:32 AM CET

Enorama Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.452.7415.771.366.8511.04
Revenue Growth
-87.20%-82.63%1061.12%-80.17%-37.96%414.26%
Gross Profit
-4.85-15.043.7-3.9-0.622.13
Operating Income
-54.51-62.12-30.5-41.82-41.97-27.33
Net Income
-59.68-75.14-43.81-44.61-42.03-27.74
Earnings Per Share
-0.83-1.08-0.83-1.61-5.37-4.48
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.13.042.096.154.1412.2
Total Debt
---0.441.913.79
Net Cash (Debt)
2.13.042.095.722.238.41
Net Cash Growth
-16.68%45.66%-63.53%156.37%-73.49%-
Net Cash Per Share
0.030.040.040.210.281.36

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-53.05-59.26-35.7-41.35-32.96-30.16
Capital Expenditures
------0.06
Free Cash Flow
-53.05-59.26-35.7-41.35-32.96-30.22
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--23.48%-287.26%-9.00%19.34%
Operating Margin
-3767.24%-2267.91%-193.44%-3079.82%-612.90%-247.63%
Pretax Margin
-4124.46%-2743.30%-277.82%-3285.20%-613.85%-251.38%
Profit Margin
-4124.46%-2743.30%-277.82%-3285.20%-613.85%-251.38%
FCF Margin
-3666.21%-2163.60%-226.42%-3044.85%-481.35%-273.87%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
36.0852.0112.8984.294.1015.50